REGENERON PHARMAC.DL-,001 earnings per share and revenue

RGO earnings per share for the last quarter are 8.85 EUR whereas the estimation was 9.43 EUR which accounts for -6.11% surprise. Company revenue for the same period amounts to 2.91 B EUR despite the estimated figure of 2.99 B EUR. Estimated earnings per share for the next quarter are 9.75 EUR, and revenue is expected to reach 3.10 B EUR. Also watch annual changes over time to get a bigger picture of RGO earnings per share and revenue dynamics.